Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Active not recruiting 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 2Thoracic 1Head & Neck 1

Conditions

Carcinoma, Non-Small-Cell Lung 21Colorectal Neoplasms 14Lung Neoplasms 9Stomach Neoplasms 5Neoplasms 5Neoplasm Metastasis 5Colonic Neoplasms 5Triple Negative Breast Neoplasms 4Squamous Cell Carcinoma of Head and Neck 4Small Cell Lung Carcinoma 4Rectal Neoplasms 4Pancreatic Neoplasms 4Ovarian Neoplasms 4Esophageal Neoplasms 4Melanoma 3Carcinoma, Renal Cell 3Carcinoma, Pancreatic Ductal 3Peritoneal Neoplasms 2Mesothelioma 2Fallopian Tube Neoplasms 2Endometrial Neoplasms 2Vipoma 1Uterine Cervical Neoplasms 1Urinary Bladder Neoplasms 1Thyroid Neoplasms 1Thymoma 1Spinocerebellar Degenerations 1Somatostatinoma 1Sezary Syndrome 1Pseudomyxoma Peritonei 1

Interventions

spartalizumab 1pembrolizumab 1Oxaliplatin 1Nivolumab 1Leucovorin 1Fulvestrant 1Fluorouracil 1E7046 1Capecitabine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Spinocerebellar Degenerations × Leucovorin × Thoracic × Clear all
NCT06544655 2026-04-17

A Study of BMS-986484 Alone and Combination Therapy in Participants With Advanced Solid Tumors

Bristol-Myers Squibb

Phase 1 Active not recruiting
213 enrolled
GastrointestinalHead & NeckThoracic

Squamous Cell Carcinoma of Head and Neck, Carcinoma, Non-Small-Cell Lung, Spinocerebellar Degenerations, Colorectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡